Merck & Co., Inc. · Whitehouse Station, NJ United States
Key Merck & Co., Inc. Financials
| Company Type | Public -
|
|---|
| Fiscal Year-End | December |
|---|
| 2009 Sales (mil.) | $27,428.3 |
|---|
| 2009 Employees | 100,000 |
|---|
For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now
Merck & Co., Inc. Income Statement
| Dec 09 | Dec 08 | Dec 07 |
| Revenue | 27,428.3 | 23,850.3 | 24,197.7 |
| Cost of Goods Sold | 9,018.9 | 5,582.5 | 6,140.7 |
| Gross Profit | 18,409.4 | 18,267.8 | 18,057.0 |
| Gross Profit Margin | 67.1% | 76.6% | 74.6% |
| SG&A Expense | 8,543.2 | 7,377.0 | 7,556.7 |
| Depreciation & Amortization | 2,576.0 | 1,631.2 | 1,988.2 |
| Operating Income | 11,406.2 | 5,053.0 | 5,290.4 |
| Operating Margin | 41.6% | 21.2% | 21.9% |
| Nonoperating Income | 8,682.3 | 4,498.6 | (2,155.1) |
| Nonoperating Expenses | (247.8) | -- | -- |
| Income Before Taxes | 15,291.8 | 9,807.8 | 3,370.7 |
| Income Taxes | 2,267.6 | 1,999.4 | 95.3 |
| Net Income After Taxes | 13,024.2 | 7,808.4 | 3,275.4 |
| Continuing Operations | 12,901.3 | 7,808.4 | 3,275.4 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 12,901.3 | 7,808.4 | 3,275.4 |
| Total Net Income | 12,901.3 | 7,808.4 | 3,275.4 |
| Net Profit Margin | 47% | 32.7% | 13.5% |
| Diluted EPS from Total Net Income | 5.65 | 1.07 | 1.49 |
| Dividends per Share | 1.52 | 1.52 | 1.52 |
All amounts in millions of US Dollars except per share amounts.
Merck & Co., Inc. Balance Sheet
| Assets | Dec 09 | Dec 08 | Dec 07 |
| Current Assets |
| Cash | 9,311.4 | 4,368.3 | 5,336.1 |
| Net Receivables | 6,602.9 | 3,778.9 | 3,636.2 |
| Inventories | 8,055.3 | 2,283.3 | 1,881.0 |
| Other Current Assets | 4,459.0 | 8,874.4 | 4,192.1 |
| Total Current Assets | 28,428.6 | 19,304.9 | 15,045.4 |
| Net Fixed Assets | 18,273.5 | 11,999.6 | 12,346.0 |
| Other Noncurrent Assets | 65,387.6 | 15,891.2 | 20,959.3 |
| Total Assets | 112,089.7 | 47,195.7 | 48,350.7 |
| Liabilities | Dec 09 | Dec 08 | Dec 07 |
| Current Liabilities |
| Accounts Payable | 2,236.9 | 617.6 | 624.5 |
| Short-Term Debt | 1,379.2 | 2,297.1 | 1,823.6 |
| Other Current Liabilities | 12,134.6 | 11,404.0 | 9,810.1 |
| Total Current Liabilities | 15,750.7 | 14,318.7 | 12,258.2 |
| Long-Term Debt | 16,074.9 | 3,943.3 | 3,915.8 |
| Other Noncurrent Liabilities | 21,206.1 | 10,175.4 | 13,992.0 |
| Total Liabilities | 53,031.7 | 28,437.4 | 30,166.0 |
| Shareholder's Equity |
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | 59,058.0 | 18,758.3 | 18,184.7 |
| Total Equity | 59,058.0 | 18,758.3 | 18,184.7 |
| Shares Outstanding (thou.) | 3,073,593.3 | 3,073,593.3 | 3,073,593.3 |
All amounts in millions of US Dollars except per share amounts.
Merck & Co., Inc. Cash Flow Statement
| Dec 09 | Dec 08 | Dec 07 |
| Net Operating Cash Flow | 3,392 | 6,572 | 6,999 |
| Net Investing Cash Flow | 3,156.0 | (1,834.4) | (2,810.0) |
| Net Financing Cash Flow | (1,638.3) | (5,522.5) | (4,866.1) |
| Net Change in Cash | 4,943.1 | (967.8) | (578.6) |
| Depreciation & Amortization | 2,576.0 | 1,631.2 | 1,988.2 |
| Capital Expenditures | (1,460.6) | (1,298.3) | (1,011.0) |
| Cash Dividends Paid | (3,479.1) | (3,278.5) | (3,307.3) |
All amounts in millions of US Dollars except per share amounts.
